PharmAsia News Spotlight On India: Smaller R&D Units To Dominate India - Study
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - India, which has now found a respectable place for itself on the global drug R&D map, could increasingly see smaller dedicated R&D units power the escalating research momentum in the country
You may also be interested in...
Amgen and India’s Jubilant In Drug Discovery Partnership
MUMBAI - Jubilant Biosys, a subsidiary of Indian contract research and manufacturing services provider Jubilant Organosys, has entered into a drug discovery partnership with Amgen to develop a portfolio of new drugs across various therapeutic areas
Amgen and India’s Jubilant In Drug Discovery Partnership
MUMBAI - Jubilant Biosys, a subsidiary of Indian contract research and manufacturing services provider Jubilant Organosys, has entered into a drug discovery partnership with Amgen to develop a portfolio of new drugs across various therapeutic areas
Indian CROs Move Up R&D Value Chain From Outsourcing Services To Partnering With MNCs
NEW DELHI - India, along with China, is increasingly becoming a popular destination for pharmaceutical research and development outsourced from the West, and more multinational companies are partnering with Indian CROs to improve productivity, cut costs and bring more drugs to market faster